Eisai's ambition to develop an integrated care system for people with dementia has taken another step forward with a decision to take control of EcoNaviSta, a specialist in software used to ...

Eisai has retreated from the optimistic view of sales growth for Alzheimer's disease drug Leqembi it held earlier this year as uptake remains sluggish. In its six-month financial report for the ...